PARSED CONTENT

The web site atryn.com states the following, "ATryn is produced through transgenic, recombinant technology independent of the supply of human plasma, with no preservatives." We noticed that the website also said " ATryn provides a homogeneous, well-defined, and abundant supply of antithrombin with distinct dosing forumlae." It also said " Framingham, MA GTC Biotherapeutics; April 2009. Echelard Y, Meade HM, Ziomek CA. The first biopharmaceutical from transgenic animals ATryn. In Knäblein J, ed." The header had anticlotting thromboembolic as the highest ranking optimized keyword. This keyword is followed by DVT, hereditary antithombin deficency, and genetic hereditary antithrombin deficiency which isn't as urgent as anticlotting thromboembolic. The other words atryn.com used was ATryn. Lundbeck is included but might not be seen by web engines.